Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Genetic therapy47 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A04639 | 33554867 | Mol Ther | Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. | 2020 | Details |
A06999 | 32666604 | FASEB J | Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. | 2020 | Details |
A09550 | 31696817 | Curr Gene Ther | Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. | 2019 | Details |
A10449 | 31333307 | World J Gastroenterol | Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. | 2019 | Details |
A10594 | 31278269 | Nat Commun | Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. | 2019 | Details |
A10707 | 31227825 | Hum Mol Genet | Recent advances in novel therapies for lipid disorders. | 2019 | Details |
A10749 | 31211621 | Am J Physiol Endocrinol Metab | Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation. | 2019 | Details |
A11672 | 30794635 | PLoS One | NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice. | 2019 | Details |
A12816 | 30271077 | World J Gastroenterol | Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. | 2018 | Details |
A13001 | 30186875 | J Diabetes Res | Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats. | 2018 | Details |
A13490 | 29951838 | Biochem Genet | Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions. | 2018 | Details |
A13512 | 29940269 | J Hepatol | Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. | 2018 | Details |
A14237 | 29511346 | Oncogene | Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. | 2018 | Details |
A15091 | 29101357 | Sci Rep | MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1. | 2017 | Details |
A18062 | 27377869 | Clin Exp Immunol | MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model. | 2016 | Details |
A19174 | 29889452 | Eksp Klin Gastroenterol | HEPATOPROTECTIVE ROLE OF PLACENTA HYDROLISAT - LAENNEC IN THE TREATMENT OF PATIENTS WITH VIRAL AND PARASITIC LIVER DISEASES. | 2018 | Details |
A20202 | 26086867 | Hum Gene Ther | Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. | 2015 | Details |
A21142 | 25518481 | Eksp Klin Gastroenterol | [Possibilities of using the noninvasive methods of investigating the morphofunctional changes in the liver in patients with non alcoholic steatohepatitis and type 2 diabetes mellitus]. | 2014 | Details |
A24326 | 22997724 | Klin Med (Mosk) | [Pathogenetic therapy of metabolic syndrome at the stage of visceral lesions]. | 2012 | Details |
A26321 | 20653983 | Lipids Health Dis | Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. | 2010 | Details |
A27134 | 20469674 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy]. | 2009 | Details |
A28683 | 35136065 | Nat Commun | In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue. | 2022 | Details |
A29509 | 33965587 | Cell Mol Gastroenterol Hepatol | Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. | 2021 | Details |
A32329 | 28707263 | Drug Deliv Transl Res | Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine. | 2018 | Details |
A33050 | 26784524 | J Immunol Methods | Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking. | 2016 | Details |
A35446 | 20660248 | J Neurosci | Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. | 2010 | Details |
A35552 | 20376096 | Gene Ther | PPARgamma is essential for protection against nonalcoholic steatohepatitis. | 2010 | Details |
A35667 | 19952284 | FASEB J | Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. | 2009 | Details |
A36240 | 18665160 | Mol Ther | Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. | 2008 | Details |
A36982 | 16779871 | J Gene Med | PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. | 2006 | Details |
A37294 | 16019264 | Mol Ther | Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. | 2005 | Details |
A37302 | 16000060 | Hum Gene Ther | Recombinant adeno-associated viral vectors in the nervous system. | 2005 | Details |
A37564 | 15352070 | J Gene Med | Hepatocyte-specific gene expression from integrated lentiviral vectors. | 2004 | Details |
A37825 | 14566362 | Gene Ther | The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen. | 2003 | Details |
A38046 | 12409257 | Mol Ther | Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. | 2002 | Details |
A44085 | 29867233 | Nat Med | Impact of neutralizing antibodies against AAV is a key consideration in gene transfer to nonhuman primates. | 2018 | Details |
A44698 | 27698966 | Middle East J Dig Dis | New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. | 2016 | Details |
A44925 | 26780008 | Curr Opin Lipidol | Gene-based therapies in lipidology: current status and future challenges. | 2015 | Details |
A45506 | 24240285 | Curr Opin Pediatr | Genetics of nonsyndromic obesity. | 2013 | Details |
A45513 | 24202306 | Arterioscler Thromb Vasc Biol | Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice. | 2013 | Details |
A46231 | 20156580 | Int J Biochem Cell Biol | Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro. | 2010 | Details |
A46694 | 16471264 | J Soc Biol | [Experimental modulation of apoptosis: physiopathological and therapeutic targets]. | 2005 | Details |
A48117 | 22699820 | Cell Mol Life Sci | Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside. | 2012 | Details |
A49033 | 20704547 | Curr Drug Targets | Heme oxygenase-1 and iron in liver inflammation: a complex alliance. | 2010 | Details |
A49047 | 20072945 | Curr Opin Mol Ther | Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency. | 2009 | Details |
A50197 | 35481220 | Exp Ther Med | Epigenetics in inflammatory liver diseases: A clinical perspective (Review). | 2022 | Details |
A52931 | 19376605 | J Hepatol | Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. | 2009 | Details |